American Academy of Neurology Study: MS Drugs Help, But Come at High Cost
In plain English by CCSVI in MS: “Bottom line: MS drugs cost too much, and we really don't know if they do anything to slow the progression of MS.” http://www.aan.com/press/index.cfm?fuseaction=release.view&release=969


Prikbordfoto's